Ingo K. Mellinghoff

37.5k citations
157 papers · 11.5k · 7 hit papers · h-index 42

Impact in

  • Genetics top 0.1%
    • Glioma Diagnosis and Treatment
    • Cancer, Hypoxia, and Metabolism
    • Cancer Genomics and Diagnostics

Papers in

Ingo K. Mellinghoff

149 papers receiving 11.3k citations

Ingo K. Mellinghoff's Hit Papers

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial 2023 · 111 citations
1110+8+16Years since publication4008001.2k

Peers

Ingo K. Mellinghoff
Comparison fields: 5 of 148
  • Genetics 3.3k
  • Cancer Research 3.6k
  • Molecular Biology 6.3k
  • Oncology 2.1k
  • Pulmonary and Respiratory Medicine 2.0k
Replace Linda M. Liau with:
Linda M. Liau United States
Jann N. Sarkaria United States
Rolf Bjerkvig Norway
Gregory J. Riggins United States
D. Williams Parsons United States
Christel Herold‐Mende Germany
Dan G. Duda United States
Kevin Camphausen United States
Daniel P. Cahill United States
Valeria R. Fantin United States
Ingo K. Mellinghoff relative to Linda M. Liau United States Linda M. Liau's profile →
Citations per field
00.5×1.5×
Linda M. Liau · 1×
Citations per year

Countries citing papers authored by Ingo K. Mellinghoff

Since Specialization
Citations

This map shows the geographic impact of Ingo K. Mellinghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo K. Mellinghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo K. Mellinghoff more than expected).

Fields of papers citing papers by Ingo K. Mellinghoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo K. Mellinghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo K. Mellinghoff. The network helps show where Ingo K. Mellinghoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Ingo K. Mellinghoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingo K. Mellinghoff Line = papers co-authored together Ingo K. Mellinghoff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.

#Work
1
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Hit paper breakdown →
20121453
2
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Hit paper breakdown →
20121382
3
A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle
Hit paper breakdown →
2012843
4
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Hit paper breakdown →
2001806
5
Glioblastoma and Other Primary Brain Malignancies in Adults
Hit paper breakdown →
2023558
6
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
Hit paper breakdown →
2005507
7 2013341
8 2009297
9 2004284
10 2004262
11 2015244
12 2007199
13 2008192
14 2006179
15 2018176
16 2012169
17 2015157
18 2016147
19 2006128
20 2006119

About Ingo K. Mellinghoff

Ingo K. Mellinghoff is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 157 papers that have together received 11.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (71 papers), Cancer, Hypoxia, and Metabolism (19 papers), Radiomics and Machine Learning in Medical Imaging (19 papers), Lymphoma Diagnosis and Treatment (15 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Cancer Genomics and Diagnostics (14 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Brain Metastases and Treatment (12 papers). The work is most often cited by research in Genetics (3.3k citations), Cancer Research (3.6k citations), Molecular Biology (6.3k citations), Oncology (2.1k citations) and Pulmonary and Respiratory Medicine (2.0k citations). Ingo K. Mellinghoff has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Charles L. Sawyers, Lauren Schaff, Chris Tran, Carl Campos, Ross L. Levine, Craig B. Thompson, Chao Lü, Patrick S. Ward, Şevin Turcan and Igor Vivanco. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Clinical Cancer Research, Proceedings of the National Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact